Access cutting-edge alopecia areata treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tolerability of bempikibart (ADX-914) in participants with severe Alopecia Areata.
Sponsor: Q32 Bio Inc.
Check if you qualify for this alopecia areata clinical trial in New Haven, CT
If you're searching for alopecia areata treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.